Routine use of nebulized emergency medication during non-invasive ventilation (NIV) using a vibrating-mesh nebulizer in pre-hospital emergency services: a pilot study (AERONIV Study)

Routine use of nebulized emergency medication during non-invasive ventilation (NIV) using a vibrating-mesh nebulizer in pre-hospital emergency services: a pilot study (AERONIV Study) - AERONIV

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038447

Enrollment

Registered

2025-11-13

Start date

2025-11-13

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J80

Interventions

Group 1: Pre-hospital emergency patients with respiratory distress and suspected bronchial obstruction who require non-invasive ventilation and are simultaneously receiving bronchodilator medication v

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Pre-hospital emergency patients who are indicated by the attending emergency physicians or paramedics for aerosol therapy with nebulisable emergency medications and for NIV therapy due to respiratory distress.

Exclusion criteria

Exclusion criteria: Age < 18 yrs pregnancy

Design outcomes

Primary

Measure	Time frame
Questionnaire on the applicability of vibrating mesh nebulisers in NIV therapy	—

Secondary

Measure	Time frame
Reduction of dyspnea, change of breathing frequency and vital parameters, frequency of NIV failure	—

Countries

Germany

Contacts

Public ContactMatthias Otto

Klinik für Anästhesiologie, operative Intensivmedizin und Schmerzmedizin, Universitätsmedizin Mannheim

matthias.otto@umm.de06213836115

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026